MAP – The game changer microneedle technology
Key benefits for pharmaceutical partners
New innovative dosage form for pain free and safety application.
Suitable for a wide variety of molecules (biologics, vaccines, small molecules).
Fast onset and sustained release options available.
Possibility to simplify and reduce healthcare costs of injectable therapies and therefore create a superior market position.
Custom design options in needle design, length, width and composition.
Potential elimination of cold chain and concomitant challenges and costs.
Opportunities for life cycle management, product extension and repurposing.
Avoidance of needlestick injuries.
Key benefits for patients
Comfortable therapy through potential avoidance of cold chain and doctor’s visit.
Self-administration creates the potential for lower healthcare costs.
Increased compliance due to convenient and pain free application.
Ideal for patients with needlestick phobias or difficulty swallowing.
Easier for children, older people and patients requiring complex care.